Cargando…

Lower Expression of TWEAK is Associated with Poor Survival and Dysregulate TIICs in Lung Adenocarcinoma

BACKGROUND: Lung cancer remains the leading cause of cancer death worldwide, and the most subtype is lung adenocarcinoma (LUAD). Tumor-infiltrating immune cells (TIICs) greatly impact the prognosis of LUAD. Tumor necrosis factor–like weak inducer of apoptosis (TWEAK), signal via its receptor fibrobl...

Descripción completa

Detalles Bibliográficos
Autores principales:	He, Zhengxi, Wang, Sai, Wu, Jinchun, Xie, Yangchun, Li, Bin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192298/ https://www.ncbi.nlm.nih.gov/pubmed/35707713 http://dx.doi.org/10.1155/2022/8661423

Ejemplares similares

Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
por: Chen, Ying, et al.
Publicado: (2020)

Dysregulation of Tweak and Fn14 in skeletal muscle of spinal muscular atrophy mice
por: Meijboom, Katharina E., et al.
Publicado: (2022)

Decreased HLF Expression Predicts Poor Survival in Lung Adenocarcinoma
por: Wang, Zaiyan, et al.
Publicado: (2021)

TWEAKing death
por: Ashwell, Jonathan D.
Publicado: (2008)

Tweaking Progranulin Expression: Therapeutic Avenues and Opportunities
por: Terryn, Joke, et al.
Publicado: (2021)

Expression of TweakR in breast cancer and preclinical activity of enavatuzumab, a humanized anti-TweakR mAb
por: Chao, Debra T., et al.
Publicado: (2012)

Expression of Tiam1 predicts lymph node metastasis and poor survival of lung adenocarcinoma patients
por: Liu, Shuguang, et al.
Publicado: (2014)

Overexpression of CHD1L is positively associated with metastasis of lung adenocarcinoma and predicts patients poor survival
por: He, Li-Ru, et al.
Publicado: (2015)

Tweaking Microtubules to Treat Scleroderma
por: van Laar, Jacob M, et al.
Publicado: (2005)

Disuse TWEAKs muscle loss
por: Short, Ben
Publicado: (2010)

The “tweaking principle” for task switching
por: Ardid, Salva, et al.
Publicado: (2014)

TWEAK Promotes Peritoneal Inflammation
por: Sanz, Ana Belen, et al.
Publicado: (2014)

Lower expression level of IL-33 is associated with poor prognosis of pulmonary adenocarcinoma
por: Yang, Min, et al.
Publicado: (2018)

TWEAKing the Hippocampus: The Effects of TWEAK on the Genomic Fabric of the Hippocampus in a Neuropsychiatric Lupus Mouse Model
por: Iacobas, Dumitru A., et al.
Publicado: (2021)

Low-Level Expression of MTUS1 Is Associated with Poor Survival in Patients with Lung Adenocarcinoma
por: Jee, Seungyun, et al.
Publicado: (2021)

Low CFB expression is independently associated with poor overall and disease-free survival in patients with lung adenocarcinoma
por: He, Chenglu, et al.
Publicado: (2021)

4221 Lower Serum TWEAK Concentration is a Biomarker for Mortality in Community Acquired Pneumonia
por: Parra, Daniela, et al.
Publicado: (2020)

SIRT1 expression is associated with poor prognosis of lung adenocarcinoma
por: Li, Chong, et al.
Publicado: (2015)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

High expression of PIMREG predicts poor survival outcomes and is correlated with immune infiltrates in lung adenocarcinoma
por: Jiang, Feng, et al.
Publicado: (2021)

Glutathione peroxidase 4 expression predicts poor overall survival in patients with resected lung adenocarcinoma
por: Liu, Chao-Yu, et al.
Publicado: (2022)

TWEAK and Fn14 in the Neurovascular Unit
por: Yepes, Manuel
Publicado: (2013)

The Role of Ubiquitination in TWEAK-Stimulated Signaling
por: Vucic, Domagoj
Publicado: (2013)

TWEAK Negatively Regulates Human Dicer
por: Lambert, Marine, et al.
Publicado: (2016)

TWEAK Progress in Dermatology: A Review
por: Kharel, Pramisha, et al.
Publicado: (2023)

Proinflammatory activity of TWEAK on human dermal fibroblasts and synoviocytes: blocking and enhancing effects of anti-TWEAK monoclonal antibodies
por: Chicheportiche, Yves, et al.
Publicado: (2002)

SCD1 is associated with tumor promotion, late stage and poor survival in lung adenocarcinoma
por: Huang, Jun, et al.
Publicado: (2016)

High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
por: Zhou, Shijie, et al.
Publicado: (2017)

Overexpression of P4HA1 Is Correlated with Poor Survival and Immune Infiltrates in Lung Adenocarcinoma
por: Zhou, Haiting, et al.
Publicado: (2020)

TWEAK: a novel biomarker for lupus nephritis?
por: Dhaun, Neeraj, et al.
Publicado: (2009)

TWEAK: A New Player in Obesity and Diabetes
por: Vendrell, Joan, et al.
Publicado: (2013)

Tweaking the catalytic efficiency of the CFTR ion channel
por: McCarty, Nael A.
Publicado: (2023)

Correction: High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma
por: Zhou, Shijie, et al.
Publicado: (2018)

Disruption of the endocannabinoid system is prominent in lung adenocarcinoma and associated with poor patient survival
por: Thu, Kelsie, et al.
Publicado: (2014)

Overexpression of major CDKN3 transcripts is associated with poor survival in lung adenocarcinoma
por: Fan, Chao, et al.
Publicado: (2015)

Epithelial cell size dysregulation in human lung adenocarcinoma
por: Sandlin, Clifford W., et al.
Publicado: (2022)

High KRT8 Expression Independently Predicts Poor Prognosis for Lung Adenocarcinoma Patients
por: Xie, Longxiang, et al.
Publicado: (2019)

RARβ2 hypermethylation is associated with poor recurrence-free survival in never-smokers with adenocarcinoma of the lung
por: Kim, Yujin, et al.
Publicado: (2015)

SPAG5 Expression Predicts Poor Prognosis and is Associated With Adverse Immune Infiltration in Lung Adenocarcinomas
por: Xiao, Gang, et al.
Publicado: (2023)

Loss of SUSD2 expression correlates with poor prognosis in patients with surgically resected lung adenocarcinoma
por: Guo, Wei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_c2d9e4a0fahaakcjvoh5nas28c